The HCPLive Cardiology condition center page is a comprehensive resource for clinical news and insights on cardiovascular and cardiometabolic diseases. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for heart disease and cardiovascular events, as well as associated diabetes, renal failure, and more...
December 8th 2024
A propensity score-matched study from ASH 2024 suggests GLP-1 RA use reduced VTE risk in type 2 diabetes.
‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
Clinical Consultations™: Addressing Elevated Phosphate Levels in Patients with END-STAGE Kidney Disease (ESKD)
View More
Thyroid Analogue Reduces Cholesterol without Heart, Bone Risks
March 15th 2010In a phase II study, eprotirome was shown to be both safe and effective in lowering cholesterol without classic thyroid risks, however it is not known whether this lowering of cholesterol will ultimately protect patients from heart disease.
I don't Understand how Some Things Come about
I think I'm rather opinionated, ok, very opinionated and also think that medicine, as noble a profession as it is, is in dire trouble. I offer my viewpoints and hope that others will read and agree with me, although I guess you get more popular if people disagree.
Exposure to Tobacco Smoke in Adolescence Leads to Arterial Changes associated with Atherosclerosis
March 5th 2010Although previous research has been conducted about the relationship between tobacco smoke and atherosclerosis in adults, a new study is one of the first about the correlation in children.